| Filed On | Filing |
|---|---|
| 06 Nov 2026 |
Form 4: Mahoney Michael F, Director
Acquired 252,241 shares (Gift) |
| 06 Nov 2026 | SCHEDULE 13G/A |
| 03 Nov 2026 |
Form 4: O'Sullivan Miriam, SVP, Chief HR Officer
Received 3,871 shares by exercise or conversion · Gave up 1,872 shares to cover exercise price or tax ($78.6K) |
| 02 Nov 2026 | 10-Q |
| 28 Oct 2026 |
8-K: Results of Operations and Financial Condition
Marlborough, Mass. (October 28, 2026) -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational1 and organic2 basis, all compared t... |
| 07 Oct 2026 |
8-K: Departure/Election of Directors or Officers; Compensation; Other Events
New operating structure designed to increase efficiency and support continued growth |
| 23 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 21, 2026, Arthur C. Butcher informed Boston Scientific Corporation (the “Company”) that he has decided to retire from his role as Executive Vice President and Group President, MedSurg and Asia Pacific effective as of January... |
| 08 Sep 2026 |
8-K: Material Cybersecurity Incidents
As previously disclosed in a Current Report on Form 8-K filed on August 26, 2026 with the Securities and Exchange Commission, on August 25, 2026, Boston Scientific Corporation (the “Company”) identified a cybersecurity incident that affe... |
| 03 Sep 2026 |
Form 4: O'Connor Padraig Andrew, EVP, Global Operations
Received 1,171 shares by exercise or conversion · Gave up 567 shares to cover exercise price or tax ($27.4K) |
| 26 Aug 2026 |
Form 4: Morano Susan E, Director
Bought 2,040 shares ($100K) |
| 26 Aug 2026 |
8-K: Other Events
On August 25, 2026, Boston Scientific Corporation (the “Company”) identified a cybersecurity incident affecting certain of its information technology systems that has resulted in a global disruption to the Company’s operations. Upon dete... |
| 12 Aug 2026 |
Form 4: Woodworth Emily, SVP, Global Controller and CAO
Acquired 2,930 shares (Discretionary Transaction) ($150K) |
| 11 Aug 2026 |
Form 4: Monson Jonathan, EVP and CFO
Acquired 9,908 shares (Discretionary Transaction) ($500K) |
| 07 Aug 2026 |
Form 4: Habiger David C, Director
Bought 2,100 shares ($99.9K) |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 05 Aug 2026 |
Form 4: Habiger David C, Director
Bought 1,042 shares ($50.1K) · Bought 140 shares ($6.8K) |
| 05 Aug 2026 |
Form 4: Mahoney Michael F, Director
Bought 186,240 shares ($9M) · Acquired 22,119 shares (Discretionary Transaction) ($1.07M) |
| 03 Aug 2026 |
Form 4: Ludwig Edward J, Director
Bought 5,000 shares ($227K) |
| 03 Aug 2026 |
Form 4: Fitzgerald Joseph Michael, EVP & Group Pres, Cardiology
Acquired 64,198 shares (Discretionary Transaction) ($3M) |
| 03 Aug 2026 | 10-Q |
Loading...